Deutsche Bank On Pharmacyclics: 'We Do Not See Much Upside' By: Benzinga via Benzinga February 25, 2015 at 17:05 PM EST In a report published Wednesday, Deutsche Bank analyst Robyn Karnauskas downgraded Pharmacyclics Inc. (NASDAQ: PCYC) to Hold, while ... Read More >> Related Stocks: Johnson & Johnson Novartis Ag ADR